≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_MALE_GENITAL_NAS_EXALLC for full statistics.

Malignant neoplasm of other and unspecified male genital organs

Endpoint Browser

C3_MALE_GENITAL_NAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only males

226837

2. Check conditions

None

226837

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C63
  • Cause of death: ICD-9 — 187
  • Cause of death: ICD-8 — 187
  • Cause of death: excluded ICD-9 — 187[1-4]
  • Cause of death: excluded ICD-8 — 1870
  • Cancer registry: Topography ICD-O-3 — C63
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

24

4. Check minimum number of events

None

24

5. Include endpoints

None

24

6. Filter based on genotype QC (FinnGen only)

24

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Not enough data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 24 - 24
Unadjusted period prevalence (%) 0.01 - 0.01
Median age at first event (years) 68.37 - 68.37

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
13
41
5.74
4.25
1.9
3.9
—
—
—
0
0
10
32
4.64
3.05
2.1
1.7
—
—
—
0
0
8
25
4.26
2.35
1.6
1.8
—
—
—
0
0
6
14
5.32
2.31
1.7
1.4
—
—
—
0
0
13
64
3.25
2.02
2.0
3.0
—
—
—
0
0
7
23
3.86
1.98
1.1
1.3
—
—
—
0
0
5
12
4.95
1.92
43.0
8.5
—
—
—
0
0
10
50
2.71
1.41
2.6
3.5
—
—
—
0
0
6
24
2.98
1.40
2.7
3.5
11.7
8.5
umol/l
—
6
19
13
75
2.60
1.39
3.9
4.7
—
—
—
0
0
12
67
2.58
1.36
2.8
2.4
—
—
—
0
0
19
136
2.90
1.31
4.9
4.6
—
—
—
0
0
19
139
2.75
1.30
38.0
26.2
329.1
333.4
g/l
0.99
19
139
18
128
2.62
1.28
4.0
4.4
—
—
—
0
0
12
71
2.38
1.17
2.1
3.7
—
—
—
0
0
11
68
2.14
0.92
4.0
3.0
—
—
—
0
0
6
32
2.16
0.89
37.7
8.1
-0.8
2.2
mmol/l
—
6
22
7
40
2.05
0.80
1.0
1.3
—
—
—
0
0
13
90
1.97
0.77
7.2
5.3
31.4
34.9
g/l
0.84
13
85
14
100
1.96
0.76
19.6
8.0
13.2
15.7
umol/l
0.33
14
95
11
74
1.90
0.69
4.0
2.8
2.7
0.8
e6/l
—
6
59
11
80
1.69
0.50
4.0
3.1
595.4
61.5
e6/l
—
6
65
5
74
0.59
0.44
2.2
3.3
5.1
93.9
mg/l
—
5
54
10
73
1.63
0.43
10.9
7.8
—
—
—
0
0
0
16
0.00
0.43
0.0
4.6
—
0.3
—
0
6
0
16
0.00
0.43
0.0
4.7
—
1.6
—
0
5
0
16
0.00
0.43
0.0
4.4
—
0.2
—
0
5
0
17
0.00
0.42
0.0
5.6
—
—
—
0
0
0
18
0.00
0.41
0.0
4.6
—
1.3
—
0
7
11
86
1.52
0.34
5.0
3.7
4410.8
71.5
e6/l
—
6
65
8
60
1.50
0.34
8.6
6.9
—
—
—
0
0
0
11
0.00
0.22
0.0
2.8
—
—
—
0
0
0
11
0.00
0.22
0.0
2.4
—
2.7
—
0
6
0
10
0.00
0.22
0.0
4.0
—
—
—
0
0
17
181
0.79
0.20
5.0
5.6
5.8
6.3
mmol/l
2.22
17
159
17
181
0.79
0.20
5.6
6.0
2.4
2.4
mmol/l
0.04
17
161
10
87
1.26
0.12
12.8
8.1
65.1
61.1
%
—
10
82
10
88
1.23
0.10
10.5
8.1
2.9
2.4
%
—
10
83
10
88
1.23
0.10
10.5
8.5
9.0
9.0
%
—
10
83
17
176
0.88
0.09
5.6
7.7
39.6
42.9
mmol/mol
0.98
17
159
10
90
1.19
0.07
12.8
8.1
19.2
24.0
%
—
10
85
0
6
0.00
0.00
0.0
5.5
—
8.1
—
0
6
0
6
0.00
0.00
0.0
1.3
—
88.9
—
0
6
0
6
0.00
0.00
0.0
1.3
—
64.7
—
0
6
0
6
0.00
0.00
0.0
1.3
—
5.0
—
0
6
0
6
0.00
0.00
0.0
5.5
—
1.5
—
0
6
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
6
58
1.05
0.00
1.8
5.9
—
—
—
0
0
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
11.3
—
0
7
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
55.3
—
0
8
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
9
86
1.07
0.00
11.6
7.9
0.8
0.5
%
—
9
81
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
6.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_MALE_GENITAL_NAS – Malignant neoplasm of other and unspecified male genital organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).